Mucormycosis is a rapidly progressive disease with an acute course, and represents a classic nosocomial condition. The prognosis is usually poor, with high mortality rates that are influenced by the timeliness of diagnosis and, above all, by the underlying status of the patient. This fungal infection commonly occurs in diabetics, immunocompromised hosts, patients with leukemia, lymphoma, multiple myeloma, septicemia, hepatitis, cirrhosis, or renal failure, as well as patients receiving chemotherapy or steroids. Intravenous drug abusers are also at risk. Early detection and treatment are key elements for patient survival. This article describes a case of mucormycosis affecting the palate in an elderly patient with uncontrolled diabetes mellitus.
Introduction
Mucormycosis is an uncommon infection caused by saprophytic fungi of the Zygomycetes class, which comprises the orders Mucorales and Entomophthorales. This rare, opportunistic fungal infection shows a rapidly progressive and fulminant course, often with fatal outcome (1, 2) . In 1800, Platauf described zygomycetes as pathogenic organisms causing disseminated disease in cancer patients.
Members of the order Mucorales have most often been implicated as pathogens in human disease and include the genera Rhizopus, Mucor, Rhizomucor, Absidia, Apophysomyces, Saksenaea, Cunninghamella, Syncephalastrum and Cok-
eromyces(3).
Rhinocerebral mucormycosis is the most recognized form of this disease, due to its severity, and oral manifestations are usually the first clinical signs (4) . This invasive, opportunistic fungal infection is usually seen in immunocompromised patients, and particularly in the setting of diabetes or immune deficiency. Colonization of the nasal mucosa is assumed to involve inhalation of spores, allowing the fungus to spread via the paranasal sinuses into the palate, pharynx, and orbits, producing facial and orbital pain, paranasal sinusitis, sloughing of the hard palate, orbital cellulitis, ophthalmoplegia, proptosis and loss of vision. Fungal hyphae can invade the blood vessels and destroy cranial nerves.
Rapid involvement of the brain, meninges, and sometimes the cavernous sinus occurs by way of the orbital apex and may prove fatal. Diabetes is the most common underlying disorder seen in affected patients (2, 4, 5) .
Case Report
A 65-year-old man living in a farming community reported to the Department of Oral Medicine and Radio-diagnosis complaining of an 8-month history of inability to eat from the right side of the mouth. Medical history included dental intervention (incision and drainage) for a swelling on the (Fig. 3) . 3D-CT comprising both axial and crosssectional views of the maxilla and paranasal sinuses demonstrated sequestrated bone in the hard palate and maxillary region (Fig. 4) . Irregular, asymmetrical, dense mucosal thickening was apparent in the right maxillary sinus with no evidence of intracranial involvement, although (Table 1 ) (8, 12) . Clinical evidence demonstrates that these phagocytes represent the major host defense mechanism against mucormycosis(8).
Amphotericin B represents the first-choice pharmacotherapy (6) . Vascular thrombosis may prevent systemic medication from reaching the fungus in necrotic tissue, so the importance of surgical debridement has been emphasized and is seen as responsible for the survival of 50% of 32 Int J Oral-Med Sci 13(1):29-33, 2014 Table 1 patients by preventing spread of the disease to the central nervous system, as in this case. Small focal lesions can often be surgically excised before progressing to involve critical structures or disseminate (8) .
Rehabilitation of a patient with oro-antral/oro-nasal communications requiring closure can be achieved surgically using free flaps or by constructing a prosthetic appliance(4).
Newer therapeutic modalities include use of hyperbaric oxygen, cytokines such as gamma interferons and granulocyte macrophage-stimulating factor.(6) Long-term Posaconazole has recently proven beneficial in diabetic patients with rhinocerebral mucormycosis (10) .
Conclusion
Cases of mucormycosis in a diabetic patient are rare and may provide a diagnostic and therapeutic dilemma for clinicians unfamiliar with the clinical presentation. The rapidly progressive nature of the pathology can prove fatal.
This geriatric patientʼs medical and oral health issues were completely ignored. The cure and care of such patients depends on thorough medical examination, early diagnosis, and reversal of predisposing conditions, followed by systemic antifungal therapy and immediate control of underlying disease processes in order to combat this disease.
